Spruce Biosciences Inc [NASDAQ: SPRB] stock went on an upward path that rose over 1378.46% on Monday, amounting to a one-week price increase of more than 1244.33%.
Over the last 12 months, SPRB stock rose by 313.97%. The one-year Spruce Biosciences Inc stock forecast points to a potential upside of 82.61. The average equity rating for SPRB stock is currently 3.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $73.48 million, with 0.56 million shares outstanding and 0.47 million shares in the current float. Compared to the average trading volume of 9.23K shares, SPRB stock reached a trading volume of 24317053 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Spruce Biosciences Inc [SPRB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SPRB shares is $750.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SPRB stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 5.57, with the Price to Cash per share for the same quarter was set at 29.09.
SPRB Stock Performance Analysis:
Spruce Biosciences Inc [SPRB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1244.33. With this latest performance, SPRB shares gained by 1348.89% in over the last four-week period, additionally plugging by 519.62% over the last 6 months – not to mention a rise of 313.97% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SPRB stock in for the last two-week period is set at 97.06, with the RSI for the last a single of trading hit 18.92, and the three-weeks RSI is set at 9.19 for Spruce Biosciences Inc [SPRB]. The present Moving Average for the last 50 days of trading for this stock 11.26, while it was recorded at 33.13 for the last single week of trading, and 15.93 for the last 200 days.
Insight into Spruce Biosciences Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Spruce Biosciences Inc [SPRB] shares currently have an operating margin of -3900.38% and a Gross Margin at 97.54%. Spruce Biosciences Inc’s Net Margin is presently recorded at -3721.17%.
Spruce Biosciences Inc (SPRB) Capital Structure & Debt Analysis
According to recent financial data for Spruce Biosciences Inc. ( SPRB), the Return on Equity (ROE) stands at -133.62%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -99.32%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Spruce Biosciences Inc’s Return on Invested Capital (ROIC) is -351.29%, showcasing its effectiveness in deploying capital for earnings.
Spruce Biosciences Inc (SPRB) Efficiency & Liquidity Metrics
Based on Spruce Biosciences Inc’s (SPRB) latest financial statements, the Debt-to-Equity Ratio is 0.14%, indicating its reliance on debt financing relative to shareholder equity.
Spruce Biosciences Inc (SPRB) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Spruce Biosciences Inc. (SPRB) effectively leverages its workforce, generating an average of -$2301904.76 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.60% and a Quick Ratio of 2.60%, indicating strong ability to cover short-term liabilities.
SPRB Stock EPS
With the latest financial reports released by the company, Spruce Biosciences Inc posted -15.75/share EPS, while the average EPS was predicted by analysts to be reported at -17.63/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 1.87. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SPRB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Spruce Biosciences Inc go to 52.27%.
Spruce Biosciences Inc [SPRB] Institutonal Ownership Details
There are presently around $19.80%, or 20.27%% of SPRB stock, in the hands of institutional investors. The top three institutional holders of SPRB stocks are: RIVERVEST VENTURE MANAGEMENT LLC with ownership of 2.94 million shares, which is approximately 7.1449%. CARLYLE GROUP INC., holding 2.9 million shares of the stock with an approximate value of $$1.52 million in SPRB stocks shares; and CARLYLE GROUP INC., currently with $$1.35 million in SPRB stock with ownership which is approximately 6.3488%.
